• Je něco špatně v tomto záznamu ?

Cytotoxic effects of Fisturalin-3 and 11-Deoxyfisturalin-3 on Jurkat and U937 cell lines

MR. Mijares, M. Ochoa, A. Barroeta, GP. Martinez, AI. Suarez, RS. Compagnone, P. Chirinos, R. Avila, JB. De Sanctis

. 2013 ; 157 (3) : 222-226.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14049952

BACKGROUND: Fisturalines are bromotyrosine compounds isolated from marine sponges. Previous studies have shown antineoplasic, antiviral and antibacterial effects in Vitro; however, the possible effects of these compounds in hematologic malignancies have not been assessed. METHODS: In the present study, the antiproliferative and pro apoptotic effects of Fistularin-3 (F) and 11-Deoxyfistularin-3 (DF) were assessed using the MTT method and annexin V/propidium iodide by flow cytometry using the cell lines: Jurkat E6.1 and U937. In addition, the cell cycle was assessed by flow cytometry. RESULTS: Inhibition of the proliferative response was concentration and time dependent. The IC50 of F was 7.39 and 8.10 µM for Jurkat E6.1 and U937 respectively. At 24 and 48 h, in the U937 cell line, but not in the Jurkat cell line, both compounds induced up to 35% annexin V increase. Necrosis was not observed in any case. Compound F induced, in both cell lines, a decrease in the number of cells in the S phase and increase in the G0/G1 phase. In the Jurkat cell line only, there was an increase in the number of cells in the G2/M phase. Compound DF was not as effective as F. CONCLUSIONS: F is more active than DF in repressing the cell cycle and inducing apoptosis. Both compounds are potentially useful in the development of new drugs to treat hematologic malignancies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14049952
003      
CZ-PrNML
005      
20200120153314.0
007      
ta
008      
140325s2013 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2012.089 $2 doi
035    __
$a (PubMed)23128821
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Mijares, Michael Rodney $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela; Facultad de Farmacia, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
245    10
$a Cytotoxic effects of Fisturalin-3 and 11-Deoxyfisturalin-3 on Jurkat and U937 cell lines / $c MR. Mijares, M. Ochoa, A. Barroeta, GP. Martinez, AI. Suarez, RS. Compagnone, P. Chirinos, R. Avila, JB. De Sanctis
520    9_
$a BACKGROUND: Fisturalines are bromotyrosine compounds isolated from marine sponges. Previous studies have shown antineoplasic, antiviral and antibacterial effects in Vitro; however, the possible effects of these compounds in hematologic malignancies have not been assessed. METHODS: In the present study, the antiproliferative and pro apoptotic effects of Fistularin-3 (F) and 11-Deoxyfistularin-3 (DF) were assessed using the MTT method and annexin V/propidium iodide by flow cytometry using the cell lines: Jurkat E6.1 and U937. In addition, the cell cycle was assessed by flow cytometry. RESULTS: Inhibition of the proliferative response was concentration and time dependent. The IC50 of F was 7.39 and 8.10 µM for Jurkat E6.1 and U937 respectively. At 24 and 48 h, in the U937 cell line, but not in the Jurkat cell line, both compounds induced up to 35% annexin V increase. Necrosis was not observed in any case. Compound F induced, in both cell lines, a decrease in the number of cells in the S phase and increase in the G0/G1 phase. In the Jurkat cell line only, there was an increase in the number of cells in the G2/M phase. Compound DF was not as effective as F. CONCLUSIONS: F is more active than DF in repressing the cell cycle and inducing apoptosis. Both compounds are potentially useful in the development of new drugs to treat hematologic malignancies.
650    _2
$a protinádorová antibiotika $x farmakologie $7 D000903
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a biologické přípravky $x farmakologie $7 D001688
650    _2
$a buněčný cyklus $x účinky léků $7 D002453
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a hematologické nádory $x farmakoterapie $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a Jurkat buňky $7 D019169
650    _2
$a tyrosin $x analogy a deriváty $x farmakologie $7 D014443
650    _2
$a U937 buňky $7 D020298
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ochoa, Mariana $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
700    1_
$a Barroeta, Amairelys $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
700    1_
$a Martinez, Gricelis Patricia $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela; Facultad de Farmacia, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
700    1_
$a Suarez, Alirica Isabel $u Facultad de Farmacia, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
700    1_
$a Compagnone, Reinaldo Santi $u Escuela de Quimica, Facultad de Ciencias, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
700    1_
$a Chirinos, Perla $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
700    1_
$a Avila, Ramona $u Facultad de Ciencias,Universidad Francisco de Miranda, Apartado 50109, Caracas 1050-A, Venezuela $7 gn_A_00010358
700    1_
$a De Sanctis, Juan Bautista $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 3 (2013), s. 222-226
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20140325 $b ABA008
991    __
$a 20200120153650 $b ABA008
999    __
$a ok $b bmc $g 1017424 $s 848522
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 157 $c 3 $d 222-226 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20140325

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...